News Conference News ESC 2024 Stop-or-Not: It’s OK to Tailor RAS Inhibitor Use Around Noncardiac Surgery Todd Neale August 30, 2024
News Daily News Drugs to Tweak RAAS Response No Help in Acute COVID-19, RCTs Show Caitlin E. Cox April 19, 2023
News Daily News Hypertension Drug Effects Differ From Person to Person, PHYSIC Trial Shows L.A. McKeown April 12, 2023
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Conference News AHA 2022 Big Drops in Blood Pressure With Baxdrostat: BrigHTN Phase II Study Michael O'Riordan November 07, 2022
News Conference News ESC 2022 CV Care Around Noncardiac Surgery: New ESC Guidelines Michael O'Riordan September 07, 2022
News Conference News ACC 2022 POISE-3: Two Perioperative BP Strategies Give Similar Results in Noncardiac Surgery Todd Neale April 06, 2022
News Daily News Retracted Over Fraud Concerns, Surgisphere ACE/ARB Study Still Gets Cited Michael O'Riordan August 03, 2021
News Daily News ARBs Preferable to ACE Inhibitors in Large Observational Hypertension Study Michael O'Riordan July 27, 2021
News Daily News Continue ACE Inhibitors/ARBs in COVID-19, New Study Confirms Michael O'Riordan April 02, 2021
News Daily News ACE Inhibitors/ARBs Appear On Par With Beta-blockers After Aortic Dissection Todd Neale March 08, 2021
News Daily News REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients Todd Neale January 13, 2021
News Daily News ACE Inhibitors, ARBs: Still No Link to COVID-19 Risks, New Analyses Show Michael O'Riordan December 21, 2020
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Conference News Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags L.A. McKeown September 10, 2020
News Conference News ESC 2020 ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA Michael O'Riordan September 01, 2020
News Daily News Higher Risk of HF After ACS for Women Previously on Beta-blockers Michael O'Riordan July 16, 2020